Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-17-027316
Filing Date
2017-11-22
Accepted
2017-11-22 17:00:25
Documents
1
Period of Report
2017-03-22

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2908
  Complete submission text file 0000899243-17-027316.txt   4481
Mailing Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-332-3410
Mirati Therapeutics, Inc. (Issuer) CIK: 0001576263 (see all company filings)

EIN.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address CAY HOUSE, EP TAYLOR DRIVE LYFORD CAY NEW PROVIDENCE C5 N7776
Business Address CAY HOUSE, EP TAYLOR DRIVE LYFORD CAY NEW PROVIDENCE C5 N7776 407-909-9970
Tuesday Thirteen Inc. (Reporting) CIK: 0001723227 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35921 | Film No.: 171220518